Healthcare Auto-injector Market: Current Trends and Future Prospects adminOctober 12, 20230111 views Autoinjector technology has been adopted in healthcare sectors for self administration of drugs during emergency and home care settings. It refers to the spring-charged needle having a pre-charged dose of medication. When the syringe is injected into the body, the device automatically activates and delivers a precise quantity of the drug. They are simple to use, cause less pain, and allow patients self-drug administration, eliminating the requirement of regular hospital visits. Since the day of introduction, auto-injectors have been adopted worldwide for the treatment of chronic diseases such as anaphylaxis, multiple sclerosis, rheumatoid arthritis, and a variety of clinical purposes. Table of Contents What Are Autoinjectors?What are the Advantages of Autoinjectors?Autoinjectors Market OverviewEmerging Trends in Autoinjectors Market§ Autoinjectors Facilitates Emergency Medical Care§ Increasing Demand for Therapeutic Drugs in Remote Settings§ Reusable Autoinjectors Are Paving The IndustryRecent News on Autoinjectors MarketKey Autoinjectors Marketing PlayersFuture of Autoinjectors MarketAbout Roots Analysis What Are Autoinjectors? Autoinjectors refer to medical devices used for self-administration of doses. They are simple to use and designed for patients who need instant medication in case of emergency. The auto-injectors have been designed with single-use syringes and pre-loaded drugs. It is a conventional medication tool that assists in delivering doses without any needle stick injuries. There are two types of auto-injectors available in the market: cartridge-based systems and prefilled syringe-based systems. These automated injectors are used for the administration of drugs via the intramuscular route or subcutaneous route. What are the Advantages of Autoinjectors? Autoinjectors offer several advantages, including accurate dosage quality, reduced chances of accidental needle sticks, and minimized needle-related anxiety disorders. With the widespread adoption of automated drug administering devices, pharmaceutical companies are focused on designing more self-administering solutions by increasing their R&D efforts, resulting in Autoinjectors market expansion. Autoinjectors Market Overview The auto-injectors have become a popular method of drug delivery in pharmaceutical sectors as well as the healthcare industry for a variety of reasons. Auto-injectors help in late-stage clinical trial processes and commercial use. These automated drug-delivering devices enable complete delivery of prescribed doses of the drug to the person, making it feasible to track data compilation during clinical trial processes. Furthermore, Autoinjectors come with prefilled doses that help to eliminate drug filling from vial and ensure correct delivery of doses. The Autoinjectors came into existence to meet the challenges of delivering drugs to patients having physical difficulties and require regular drug administration but unable to reach hospitals for daily medications. To address these challenges, an auto-injector for intramuscular injection has been introduced in the market, offering physiological benefits to patients. In addition, several autoinjectors market players including Novartis, Teva Pharmaceuticals and Ypsomed are working on incorporating advanced features in autoinjectors include Bluetooth connectivity, integrated needle safety, monitoring injection dose history, and drug dose management. FDA has approved some of the autoinjector-based combination products such as Fasenra® Pen (October 2019), Gvoke® Hypopen (September 2019) and NUCALA Autoinjector (December 2017). It is worth to note that since 2015 around 5,000 patents have been granted for autoinjectors and technologies. Since, more pharmaceutical players are showing keen interest in the autoinjectors market, the global autoinjectors market is estimated to grow at a CAGR of 8.2% during the forecast period, according to Roots Analysis. Emerging Trends in Autoinjectors Market Advancements in technology and pharmaceutical companies have fueled the Auto-injectors market. § Autoinjectors Facilitates Emergency Medical Care Autoinjectors provide a wide range of benefits, such as faster and easier administration of drugs. Several conditions, such as anaphylactic shocks that are caused due to insect stings, food allergies, and drug allergies, require immediate medical dosage. Therefore to treat patients with anaphylactic shocks, epinephrine For instance, adrenaline autoinjectors serve as a lifesaver option for patients with anaphylaxis. It is a serious allergic reaction that occurs when an individual is exposed to potential allergens such as insect stings, food, pollen, and medications. In the case of anaphylaxis, the sudden shock reaction can lead to a drop in blood pressure, cause breathing sickness, and narrowing of the airways. In such instances, autoinjectors loaded with adrenaline or epinephrine help patients deal with anaphylaxis. Autoinjectors are introduced as they serve as emergency medical care, making them an ideal option for quick administration of medicine. The benefits offered by these Autoinjectors during an emergency are anticipated to support the auto-injector manufacturers in designing innovative solutions for instant drug administration. § Increasing Demand for Therapeutic Drugs in Remote Settings Chronic diseases such as diabetes increase the risk of complications such as vision loss, cardiovascular disease, peripheral neuropathy and leads to amputation, enabling patients to visit hospitals multiple times for the treatment. According to the report of the World Health Organization, there are 422 million people worldwide who have type 2 diabetes. Within the past few decades, cases of diabetes have increased dramatically. The diabetic patients require immediate medical attention in case of high blood sugar level. Thus, autoinjector manufacturers put their focus on the development of advanced Autoinjectors for easy administration and patient handling in home care settings. With technological advancements, key market players such as Amgen, AstraZeneca, Bayer, Becton and Biogen are also working on manufacturing connected autoinjectors for the administration of large doses, consequently bringing new opportunities in the market. § Reusable Autoinjectors Are Paving The Industry Autoinjectors are divided into two broad categories on the basis of usage: disposable autoinjectors and reusable autoinjectors. The reusable autoinjectors are in great demand because they have a patient-centric design, making them a great self drug administration for patients with low dexterity and visual impairment. Therefore, many autoinjector market players are emphasizing on designing reusable auto injectors for the patients to meet with emergency medication requirements as in case of rheumatoid arthritis. Rheumatoid arthritis has affected millions of people worldwide. This is an autoimmune disease in which the immune system begins to attack joins, resulting in severe pain, swelling, and inflammation of the synovium. Patients who have rheumatoid arthritis face physical challenges such as difficulty in movement. They require immediate drug administration to overcome their symptoms. Therefore, Autoinjectors are widely used for the treatment of rheumatoid arthritis patients. In fact, the patients who are using Autoinjectors are comfortable in using these devices because they are easy to use. Furthermore, the rapid adoption of these devices in healthcare sectors for emergency treatment is expected to boost the market growth. Recent News on Autoinjectors Market Some of the recent news of the autoinjector market are as follows. ⬝ In April 2022, Teva Pharmaceuticals has reported the availability of auto-injectors for AJOVY® injections (fremanezumab-vfrm) in the USA━serving as an anti-CGRP (calcitonin gene-related peptide) preventive treatment of migraine with a monthly (225 mg) subcutaneous dosage option. ⬝ In March 2022, NORDIC Pharma, which is a Life Science Company, has submitted a New Drug Submission to Health Canada for the launch of Nordimet®, a methotrexate auto-injector in the market for the treatment of rheumatoid arthritis and disabling psoriasis in the adults who are not responding to other therapies. Key Autoinjectors Marketing Players Some of the key auto-injector manufacturers are as follows: § Abbvie § Amgen § AstraZeneca § Bayer § Becton § Dickinson and Company § Biogen § Eli Lilly § Novartis § Teva Pharmaceuticals § Ypsomed Future of Autoinjectors Market Overall, Autoinjectors provide significant advantages in delivering accurate doses to patients with chronic diseases. Autoinjectors have helped to reduce the burden on the healthcare industry to provide care to patients in home settings. The use of Autoinjectors helps to improve patient compliance and reduce adverse reactions to doses at administration sites. Most of the sources analyzed above indicate that Autoinjectors manufacturers focus on delivering more self-administering solutions and large volume Autoinjectors so patients can live a quality life. About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.